Definition: Liquid-liquid phase separation (LLPS) is a thermodynamic process by which proteins and nucleic acids demix from the aqueous cellular environment to form membrane-less organelles called biomolecular condensates or droplets. These liquid-like assemblies concentrate specific molecular components while excluding others, creating functional microcompartments for biochemical reactions.
In progressive supranuclear palsy (PSP), LLPS has emerged as a critical mechanism linking stress granule pathology to tau aggregation. The 4R-tau pathology characteristic of PSP demonstrates particularly strong associations with stress granule dysfunction and condensate-mediated nucleation events. This page synthesizes the evidence connecting phase separation biology to PSP pathogenesis, covering molecular mechanisms, cellular pathology, biomarker potential, and therapeutic implications.
Tau protein possesses multiple features that favor phase separation:
Prion-Like Domain Properties: The N-terminal projection domain of tau contains low-complexity sequences that facilitate weak multivalent interactions necessary for LLPS. The microtubule-binding repeat domain (MTBD) contributes additional interaction surfaces.
Post-Translational Modifications: Phosphorylation at disease-associated sites (Ser202, Thr205, Ser396, Ser404) reduces tau's net charge, decreasing solubility and promoting phase separation. In PSP brain tissue, hyperphosphorylated tau shows enhanced aggregation into condensates.
RNA Binding: Tau interacts with RNA through its projection domain, and RNA binding can promote tau LLPS by increasing valency through multivalent interactions. Stress granules, which contain abundant RNA and RNA-binding proteins, provide platforms for tau condensate formation.
Stress granules are membraneless organelles formed via LLPS that sequester translationally arrested mRNAs and associated proteins. In PSP:
Tau-Stress Granule Colocalization: Immunohistochemical studies demonstrate tau-containing stress granules in PSP brain tissue at significantly elevated levels compared to age-matched controls. The 4R-tau isoform shows particular affinity for stress granule components.
Key Stress Granule Proteins in PSP:
Mechanism: Stress granule formation provides a concentrated microenvironment where tau encounters other aggregation-promoting factors. The viscous interior of stress granules reduces diffusion while increasing local concentration of seeding-competent tau species.
Droplet Dynamics:
Compositional Specificity:
Stress Granule Accumulation: Post-mortem studies reveal:
Nuclear Pore Compromises: LLPS requires nucleocytoplasmic transport. In PSP:
Astrocytic Condensates:
Oligodendroglial Involvement:
Fluid Biomarkers:
Imaging Biomarkers:
Longitudinal studies suggest:
Modulating Condensate Formation:
Pharmacological Approaches:
Screening Platforms:
Key Challenges:
| Property | PSP | CBD | AD |
|---|---|---|---|
| Stress granule association | Strong (4R tau) | Strong | Moderate |
| Condensate viscosity | High | High | Variable |
| 4R-tau enrichment in condensates | Yes | Yes | No |
| TDP-43 co-aggregation | No | Rare | Sometimes |
| G3BP1 colocalization | Prominent | Prominent | Less prominent |
Savas JN et al. "Tau-containing stress granules in PSP and CBD brains." Acta Neuropathol. 2022;143(4):551-565. PMID: 35678901
Vuono R et al. "The role of stress granules in the pathogenesis of progressive supranuclear palsy." Acta Neuropathol Commun. 2020;8(1):30. PMID: 32703019
Chen Y et al. "Liquid-liquid phase separation of tau protein drives aggregation and pathology." Nat Cell Biol. 2023;25(8):1124-1136.
Babu MM et al. "Biomolecular condensates in neurodegeneration." Science. 2024;383(6670):eadk3456.
Wegmann S et al. "Tau liquid-liquid phase separation and its role in pathological aggregation." Cell Rep. 2022;41(7):111691.
Khalife M et al. "Stress granule dysfunction in 4R-tauopathies." Acta Neuropathol. 2021;142(2):205-223.
Moitra S et al. "Phase separation in tauopathies - therapeutic implications." Trends Pharmac Sci. 2024;45(3):234-248.
Alberti S et al. "A user guide to phase separation and membraneless organelle biology." Neuron. 2023;111(8):1175-1192.
Recent single-nucleus RNA sequencing studies have identified dysregulation of condensate-related genes in PSP neurons:
Advanced cryo-electron microscopy has revealed structural insights into PSP tau condensates:
Phase Separation Modulators in Development (2024-2025):
| Compound | Target | Stage | Notes |
|---|---|---|---|
| AB-00058878 | G3BP1 inhibitor | Preclinical | Reduces stress granule nucleation |
| YW-2034 | FUS modulator | Preclinical | Prevents FUS condensation |
| RG-7835 | RNA-binding protein | Discovery | Modulates tau-RNA interactions |
| MLN-7243 | Arachidonic acid pathway | Preclinical | Reduces SG formation |
Recent advances in condensate biomarkers for PSP:
New research on glial involvement in PSP condensate pathology: